Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-07-24)

USD 26.90-0.44%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

3.15 12 votes No rating yet

NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-1.47%1Y

-36.1%3Y

-67.5%5Y

Performance

80.1%1Y

59.4%3Y

56.8%5Y

Volatility

2649 M

Market cap (USD)

1,495,624

Daily traded volume (Shares)

43.045 / 41.53

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.15

12 votes

Performance:

3.50

Innovation:

3.45

Society:

3.43

Nature:

3.20

Hazem Baderon

Malaysia, 20 May 2026

Still consolidating, might be ok for long term

Han Yee Kong

Malaysia, 29 Apr 2026

.

oliver baigel

UK, 09 Nov 2025

a very low performing stock with a high level of risk

EQUITIES OF THE SAME SECTOR

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

0.80%SEK 276.30

Aster DM Healthcare Ltd.

Aster DM Healthcare Ltd. Valor: 40341147

Annual Return

-50%0%+50%

Risk level

110

-0.07%INR 784.00

Bruker Corp

Bruker Corp Valor: 1635622

Annual Return

-50%0%+50%

Risk level

110

-2.74%USD 60.45

Vitrolife AB

Vitrolife AB Valor: 41707777

Annual Return

-50%0%+50%

Risk level

110

-0.41%SEK 85.20

Elekta AB

Elekta AB Valor: 613625

Annual Return

-50%0%+50%

Risk level

110

2.84%SEK 47.00

Agenus Inc

Agenus Inc Valor: 134326284

Annual Return

-50%0%+50%

Risk level

110

-3.39%USD 5.98

BioArctic AB

BioArctic AB Valor: 38514501

Annual Return

-50%0%+50%

Risk level

110

0.85%SEK 309.40

ImmunityBio Inc

ImmunityBio Inc Valor: 110468647

Annual Return

-50%0%+50%

Risk level

110

-4.05%USD 7.10

Medios AG

Medios AG Valor: 19069483

Annual Return

-50%0%+50%

Risk level

110

-0.48%EUR 12.48

Dyne Therapeutics Inc

Dyne Therapeutics Inc Valor: 56806425

Annual Return

-50%0%+50%

Risk level

110

2.30%USD 24.44

SIX

FactSet

Clearbit

Logos provided by Clearbit